Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Genetic Studies Designed to Diagnose and Treat Complex Diseases

By Biotechdaily staff writers
Posted on 09 May 2007
A genome-wide human single nucleotide polymorphisms (SNP) array 5.0 has been chosen to genotype more than 17,000 individuals.

The German National Genome Research Network (NGFN, Bonn, Germany) has selected Affymetrix (Santa Clara, CA, USA) technology to help researchers better understand the underlying causes and develop more effective treatments for 25 complex diseases, including Alzheimer's, epilepsy, heart diseases, malaria, and Parkinson's. More...
The NGFN will use the new SNP array 6.0 when it becomes available later this year.

With this large-scale project, we hope to encourage the launch of further projects of this kind, said Prof. Stefan Schreiber of the University of Kiel (Germany). Our aim is to discover how similar diseases are linked in order to identify genes related to multiple diseases. In near time, the global community will have the chance of a joint analysis across countries using multiple association samples. The ability to analyze large sample cohorts such as these with cutting-edge technologies is crucial to understanding complex genetics.

The latest NGFN project builds on the success of the first project, which focused on developing a control cohort database that would be free and available to the public. The database is enabling researchers from both academia and the pharmaceutical industry to reduce the number of required control samples and increase the genetic power of their current studies by adding age- and sex-matched controls from similar ethnic backgrounds as their cases. As a result of this project and others around the world, the Affymetrix Control Program is now the world's largest population genetics resource, containing genotype data from more than 12,000 samples.

The project is part of one of the world's largest genetic research efforts. The NGFN consists of a team of scientists from more than 10 research institutions around the country who are committed to standardizing the set of controls, protocols, and analysis tools for whole-genome association studies. Results of the studies will flow into a database accessible to both researchers from academia and the pharmaceutical industry.

The Affymetrix SNP array 5.0 was developed to help researchers better identify and understand the genetic variations associated with complex diseases, such as autism, bipolar disease, cancer, diabetes, and heart disease. The SNP array 5.0 features from the original Affymetrix two-chip 500K array set, as well as 420,000 additional probes that can measure other genetic differences, such as copy number variation. The SNP array 5.0 gives researchers a significant increase in information above the original 500K array set for the same price, while reducing the array processing time. The NGFN will also have access to the next-generation SNP array 6.0, which is expected to be available later this year.


Related Links:
Affymetrix
University of Kiel

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DOA Urine MultiPlex is available on the fully automated Evidence MultiSTAT multi‑analyte analyzer (Photo courtesy of Randox)

Rapid Testing Panel Simultaneously Detects 15 Drugs of Abuse in Urine Within 21 Minutes

Illicit drug use and excessive use of prescription medicine is growing across the US amid a severe opioid crisis. Although overdose fatalities were reported to have declined by nearly 27% in 2024, many... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.